Crossmark

Synergizing tyrosine kinase inhibitors with structurally diverse natural products: strategies to enhance efficacy and overcome drug resistance in liver cancer

Crossref DOI link: https://doi.org/10.1007/s44345-025-00016-w

Published Online: 2025-04-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Chen, Jia-Wen

Chen, Sibao

Chen, Guo-Qing https://orcid.org/0000-0002-3671-5257
Funding

Funding for this research was provided by:

Innovation and Technology Fund-Mainland-Hong Kong Joint Funding Scheme (MHP/010/20)

Shenzhen Science and Technology Innovation Commission (JCYJ20220531090802006)
License Information

Text and Data Mining valid from 2025-04-03

Version of Record valid from 2025-04-03
More Information

Article History

Received: 22 November 2024

Accepted: 17 March 2025

First Online: 3 April 2025

Declarations

:

: The author is accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below